Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383318 · ClinicalTrials.gov registry record
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 450
- Enrollment target
NCT00383318: Completed study, sponsored by Pediatrix.
NCT00383318 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00383318 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
Interventions
- PROCEDURE Gene mutation sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-12 |
What the finished NCT00383318 record still lists
NCT00383318 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Gene mutation sample is the first listed.
NCT00383318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00383318 about?
NCT00383318 is a clinical study titled "Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia". The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
What is the current status of trial NCT00383318?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2006-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00383318?
The interventions under investigation include: Gene mutation sample (PROCEDURE).
Who is sponsoring clinical trial NCT00383318?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia